盘点:缺血性卒中近期重要研究进展一览

2018-06-26 MedSci MedSci原创

缺血性脑卒中是指因脑部血液供应障碍,缺血、缺氧所导致的局限性脑组织的缺血性坏死或软化。脑梗死的临床症状与脑损害的部位、缺血的严重程度等有关,患者会出现偏瘫、面瘫、失语,严重还会导致昏迷、继发脑水肿等。这里梅斯小编整理了近期关于缺血性卒中的重要研究进展,与大家一同分享。【1】阻塞性睡眠呼吸暂停对急性缺血性卒中患者心脏器官损害的影响阻塞性睡眠呼吸暂停(OSA)和心脏器官损伤在急性缺血性卒中患者中发挥着

缺血性脑卒中是指因脑部血液供应障碍,缺血、缺氧所导致的局限性脑组织的缺血性坏死或软化。脑梗死的临床症状与脑损害的部位、缺血的严重程度等有关,患者会出现偏瘫、面瘫、失语,严重还会导致昏迷、继发脑水肿等。这里梅斯小编整理了近期关于缺血性卒中的重要研究进展,与大家一同分享。

【1】阻塞性睡眠呼吸暂停对急性缺血性卒中患者心脏器官损害的影响

阻塞性睡眠呼吸暂停(OSA)和心脏器官损伤在急性缺血性卒中患者中发挥着关键作用。近日,一项研究探究了急性卒中患者OSA与心脏器官损伤之间的关系。研究招募了130例连续就诊的急性缺血性卒中患者。结果发现,与没有OSA的患者相比,急性卒中和OSA患者的LV质量指数、IVS和LVPW厚度显着增加以及左心房显著扩大。伴有和不伴有OSA的卒中患者之间左室射血分数没有显著差异,并处于正常范围内。在心脏改变、OSA发生和高血压病史之间没有发现相关性。由此可见,与不伴有OSA的患者相比,伴有OSA的急性卒中患者左心室质量较大,左心房扩大。研究人员发现伴有OSA的急性卒中患者的结构性LV异常提示OSA作为决定脑血管和心脏损伤促进因素的潜在作用,即使与血压升高病史之间没有明确的关系。

【2】年轻人吸烟与缺血性卒中的风险

吸烟与年轻女性缺血性卒中风险之间存在强烈的剂量-反应关系,但在年轻男性中很少有研究这种关联的数据。近日,研究人员评估了50岁以下男性吸烟量与缺血性卒中发生几率之间的剂量-效应关系。研究纳入了615例患者和530例对照者。当前吸烟者与不吸烟者的比值比为1.88。此外,当前吸烟组按吸烟量分层时,比值比存在剂量-效应关系,比值比从每天吸烟小于11支的1.46到每天吸烟超过40支的5.66波动。由此可见,青年人吸烟量与缺血性脑卒中之间存在剂量-效应关系。虽然戒烟完全是目的,但即使减少吸烟也能降低年轻人缺血性卒中的风险。

【3】低水平小窝蛋白-1预测急性缺血性卒中患者溶栓治疗后症状性出血

卒中早期血压控制以降低卒中后认知障碍(PSCI)的风险存在争议。近日,一项研究探讨了缺血性卒中和卒中亚型早期血压水平对PSCI的影响。研究人员对七百九十六例急性缺血性脑卒中患者进行回顾性分析,并使用蒙特利尔认知评估对卒中发作后的认知功能进行评估。结果发现,缺血性卒中早期血压较低或较高均与3个月PSCI风险增加有关。维持收缩压/舒张压在143-158/93-102mmHg有助于减少PSCI的发生。而大动脉硬化亚型和前循环梗死亚型与3个月PSCI风险增加相关。

【4】动脉粥样硬化所致的亚急性缺血性卒中患者强化降压治疗不安全

目前的指南建议高血压患者进行强化血压(BP)控制,但由于缺血性狭窄导致的缺血性脑卒中后适当的血压水平仍不确定。近日,一项随机、单盲试验中,2010年4月至12月20日期间,症状性颈内动脉或大脑中动脉狭窄闭塞(>50%)的卒中患者7-42天内接受强化(SBP<120mmHg)或适度(SBP<140mmHg)血压控制。132例患者中,111例参与者获得随访FLAIR图像。24周后,强化降压组SBP明显低于对照组。与对照组相比,强化降压组的缺血灶体积增加,未显示出非劣性。24周FLAIR图像中新发缺血病灶的频率在强化降压组中明显高于对照组。在研究期间,每组只有一例复发性卒中患者。由此可见,脑动脉狭窄患者强化血压控制与适度血压控制相比,无明显优势,可增加亚急性期缺血性病灶体积。

【5】短暂性脑缺血发作或轻微缺血性卒中后五年卒中风险

短暂性脑缺血发作(TIA)或轻微卒中后,卒中和其他血管事件的长期风险尚不明确。最近, NEJM上一项研究报告了来自21个国家的TIA诊所登记中心招募的4789例TIA或轻微缺血性卒中患者随访1年的结局,研究人员评估了卒中和血管事件的5年风险。研究人员评估了在登记中心招募前7天内患有TIA或轻微卒中的患者。在5年随访研究中共纳入了3847例患者,469例患者发生主要结局复合事件,235次事件发生在第二至第五年。在5年时,345例患者发生卒中,其中149例患者在第二至第五年内发生卒中。5年时,全因死亡、心血管死亡、颅内出血死亡和大出血死亡的发生率分别为10.6%、2.7%、1.1%和1.5%。在对患有TIA或轻微卒中的患者进行为期1年的随访研究后,在选定的队列中,包括脑卒中在内的心血管事件的发生率在第一年为6.4%,第二至第五年为6.4%。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1806256, encodeId=c97b180625681, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 16 17:52:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328408, encodeId=70ae3284086a, content=学习了.学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 01 09:32:43 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327788, encodeId=46aa32e7883d, content=值得关注.收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpuibzKNmhugibMhVhibQ2qetcsK3UDo9nImuKxqcXNXibypcdCCMYT8FYfDJLpuCfIVT4L2gmovxAVw/132, createdBy=53ba2388591, createdName=JJZ, createdTime=Thu Jun 28 23:28:19 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893074, encodeId=ecb318930e473, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Oct 02 19:52:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1381040, encodeId=677d138104027, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jun 28 13:52:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026088, encodeId=df48102608829, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jun 27 01:52:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327294, encodeId=9fc832e294bf, content=非常值得关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:41 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327293, encodeId=eff432e29363, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:29 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327289, encodeId=db8432e28988, content=谢谢分享.持续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:31 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327288, encodeId=e97832e288b4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:07 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1806256, encodeId=c97b180625681, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 16 17:52:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328408, encodeId=70ae3284086a, content=学习了.学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 01 09:32:43 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327788, encodeId=46aa32e7883d, content=值得关注.收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpuibzKNmhugibMhVhibQ2qetcsK3UDo9nImuKxqcXNXibypcdCCMYT8FYfDJLpuCfIVT4L2gmovxAVw/132, createdBy=53ba2388591, createdName=JJZ, createdTime=Thu Jun 28 23:28:19 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893074, encodeId=ecb318930e473, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Oct 02 19:52:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1381040, encodeId=677d138104027, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jun 28 13:52:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026088, encodeId=df48102608829, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jun 27 01:52:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327294, encodeId=9fc832e294bf, content=非常值得关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:41 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327293, encodeId=eff432e29363, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:29 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327289, encodeId=db8432e28988, content=谢谢分享.持续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:31 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327288, encodeId=e97832e288b4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:07 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-07-01 虈亣靌

    学习了.学习了.学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1806256, encodeId=c97b180625681, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 16 17:52:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328408, encodeId=70ae3284086a, content=学习了.学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 01 09:32:43 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327788, encodeId=46aa32e7883d, content=值得关注.收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpuibzKNmhugibMhVhibQ2qetcsK3UDo9nImuKxqcXNXibypcdCCMYT8FYfDJLpuCfIVT4L2gmovxAVw/132, createdBy=53ba2388591, createdName=JJZ, createdTime=Thu Jun 28 23:28:19 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893074, encodeId=ecb318930e473, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Oct 02 19:52:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1381040, encodeId=677d138104027, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jun 28 13:52:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026088, encodeId=df48102608829, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jun 27 01:52:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327294, encodeId=9fc832e294bf, content=非常值得关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:41 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327293, encodeId=eff432e29363, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:29 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327289, encodeId=db8432e28988, content=谢谢分享.持续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:31 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327288, encodeId=e97832e288b4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:07 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-06-28 JJZ

    值得关注.收藏!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1806256, encodeId=c97b180625681, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 16 17:52:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328408, encodeId=70ae3284086a, content=学习了.学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 01 09:32:43 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327788, encodeId=46aa32e7883d, content=值得关注.收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpuibzKNmhugibMhVhibQ2qetcsK3UDo9nImuKxqcXNXibypcdCCMYT8FYfDJLpuCfIVT4L2gmovxAVw/132, createdBy=53ba2388591, createdName=JJZ, createdTime=Thu Jun 28 23:28:19 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893074, encodeId=ecb318930e473, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Oct 02 19:52:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1381040, encodeId=677d138104027, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jun 28 13:52:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026088, encodeId=df48102608829, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jun 27 01:52:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327294, encodeId=9fc832e294bf, content=非常值得关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:41 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327293, encodeId=eff432e29363, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:29 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327289, encodeId=db8432e28988, content=谢谢分享.持续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:31 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327288, encodeId=e97832e288b4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:07 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1806256, encodeId=c97b180625681, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 16 17:52:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328408, encodeId=70ae3284086a, content=学习了.学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 01 09:32:43 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327788, encodeId=46aa32e7883d, content=值得关注.收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpuibzKNmhugibMhVhibQ2qetcsK3UDo9nImuKxqcXNXibypcdCCMYT8FYfDJLpuCfIVT4L2gmovxAVw/132, createdBy=53ba2388591, createdName=JJZ, createdTime=Thu Jun 28 23:28:19 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893074, encodeId=ecb318930e473, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Oct 02 19:52:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1381040, encodeId=677d138104027, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jun 28 13:52:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026088, encodeId=df48102608829, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jun 27 01:52:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327294, encodeId=9fc832e294bf, content=非常值得关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:41 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327293, encodeId=eff432e29363, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:29 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327289, encodeId=db8432e28988, content=谢谢分享.持续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:31 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327288, encodeId=e97832e288b4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:07 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1806256, encodeId=c97b180625681, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 16 17:52:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328408, encodeId=70ae3284086a, content=学习了.学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 01 09:32:43 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327788, encodeId=46aa32e7883d, content=值得关注.收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpuibzKNmhugibMhVhibQ2qetcsK3UDo9nImuKxqcXNXibypcdCCMYT8FYfDJLpuCfIVT4L2gmovxAVw/132, createdBy=53ba2388591, createdName=JJZ, createdTime=Thu Jun 28 23:28:19 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893074, encodeId=ecb318930e473, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Oct 02 19:52:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1381040, encodeId=677d138104027, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jun 28 13:52:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026088, encodeId=df48102608829, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jun 27 01:52:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327294, encodeId=9fc832e294bf, content=非常值得关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:41 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327293, encodeId=eff432e29363, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:29 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327289, encodeId=db8432e28988, content=谢谢分享.持续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:31 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327288, encodeId=e97832e288b4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:07 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-06-27 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1806256, encodeId=c97b180625681, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 16 17:52:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328408, encodeId=70ae3284086a, content=学习了.学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 01 09:32:43 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327788, encodeId=46aa32e7883d, content=值得关注.收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpuibzKNmhugibMhVhibQ2qetcsK3UDo9nImuKxqcXNXibypcdCCMYT8FYfDJLpuCfIVT4L2gmovxAVw/132, createdBy=53ba2388591, createdName=JJZ, createdTime=Thu Jun 28 23:28:19 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893074, encodeId=ecb318930e473, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Oct 02 19:52:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1381040, encodeId=677d138104027, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jun 28 13:52:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026088, encodeId=df48102608829, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jun 27 01:52:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327294, encodeId=9fc832e294bf, content=非常值得关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:41 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327293, encodeId=eff432e29363, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:29 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327289, encodeId=db8432e28988, content=谢谢分享.持续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:31 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327288, encodeId=e97832e288b4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:07 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-06-27 深海蓝

    非常值得关注一下

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1806256, encodeId=c97b180625681, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 16 17:52:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328408, encodeId=70ae3284086a, content=学习了.学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 01 09:32:43 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327788, encodeId=46aa32e7883d, content=值得关注.收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpuibzKNmhugibMhVhibQ2qetcsK3UDo9nImuKxqcXNXibypcdCCMYT8FYfDJLpuCfIVT4L2gmovxAVw/132, createdBy=53ba2388591, createdName=JJZ, createdTime=Thu Jun 28 23:28:19 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893074, encodeId=ecb318930e473, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Oct 02 19:52:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1381040, encodeId=677d138104027, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jun 28 13:52:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026088, encodeId=df48102608829, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jun 27 01:52:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327294, encodeId=9fc832e294bf, content=非常值得关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:41 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327293, encodeId=eff432e29363, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:29 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327289, encodeId=db8432e28988, content=谢谢分享.持续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:31 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327288, encodeId=e97832e288b4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:07 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-06-27 深海蓝

    非常实用

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1806256, encodeId=c97b180625681, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 16 17:52:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328408, encodeId=70ae3284086a, content=学习了.学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 01 09:32:43 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327788, encodeId=46aa32e7883d, content=值得关注.收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpuibzKNmhugibMhVhibQ2qetcsK3UDo9nImuKxqcXNXibypcdCCMYT8FYfDJLpuCfIVT4L2gmovxAVw/132, createdBy=53ba2388591, createdName=JJZ, createdTime=Thu Jun 28 23:28:19 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893074, encodeId=ecb318930e473, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Oct 02 19:52:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1381040, encodeId=677d138104027, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jun 28 13:52:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026088, encodeId=df48102608829, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jun 27 01:52:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327294, encodeId=9fc832e294bf, content=非常值得关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:41 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327293, encodeId=eff432e29363, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:29 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327289, encodeId=db8432e28988, content=谢谢分享.持续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:31 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327288, encodeId=e97832e288b4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:07 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-06-27 深海蓝

    谢谢分享.持续学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1806256, encodeId=c97b180625681, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jan 16 17:52:00 CST 2019, time=2019-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328408, encodeId=70ae3284086a, content=学习了.学习了.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 01 09:32:43 CST 2018, time=2018-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327788, encodeId=46aa32e7883d, content=值得关注.收藏!, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpuibzKNmhugibMhVhibQ2qetcsK3UDo9nImuKxqcXNXibypcdCCMYT8FYfDJLpuCfIVT4L2gmovxAVw/132, createdBy=53ba2388591, createdName=JJZ, createdTime=Thu Jun 28 23:28:19 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893074, encodeId=ecb318930e473, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Tue Oct 02 19:52:00 CST 2018, time=2018-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1381040, encodeId=677d138104027, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Thu Jun 28 13:52:00 CST 2018, time=2018-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026088, encodeId=df48102608829, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Wed Jun 27 01:52:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327294, encodeId=9fc832e294bf, content=非常值得关注一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:41 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327293, encodeId=eff432e29363, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:28:29 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327289, encodeId=db8432e28988, content=谢谢分享.持续学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:31 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327288, encodeId=e97832e288b4, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLzTvXX2lsnbVCeL7ACpHxSiaonreKC4jVxklLSbTWeTlnrlb61gYxibz2yJ9p7lTeClsRs0txS2IEw/132, createdBy=3f271833551, createdName=深海蓝, createdTime=Wed Jun 27 01:23:07 CST 2018, time=2018-06-27, status=1, ipAttribution=)]
    2018-06-27 深海蓝

    学习

    0